GenSight Biologics

Paris, France

GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases.

Mar 2026

Post-IPO Equity

Biotechnology Genetics Health Care Medical

Top Investors

European Investment BankBpifranceIndex VenturesSofinnova PartnersPerceptive Advisors

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about GenSight Biologics

Who are GenSight Biologics's investors?

GenSight Biologics's investors include European Investment Bank, Bpifrance, Index Ventures, Sofinnova Partners, Perceptive Advisors.

Where is GenSight Biologics headquartered?

GenSight Biologics is headquartered in Paris, France.

What does GenSight Biologics do?

GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases.

What stage is GenSight Biologics at?

GenSight Biologics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 10, 2026.

MLA

"GenSight Biologics — Funding & Investors." VCBacked, March 10, 2026, https://www.vcbacked.co/company/gensight-biologics. Accessed July 1, 2026.

APA

VCBacked. (2026). GenSight Biologics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/gensight-biologics

Wikipedia (cite web)

{{cite web |title=GenSight Biologics — Funding & Investors |url=https://www.vcbacked.co/company/gensight-biologics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 10, 2026.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.